Based on bioinformatical analysis of transcriptome sequencing and Co-IP, our research demonstrated that CPNE7 acts as an oncogene, possibly by binding with PKM2 in CRC cells to activate the MAPK pathway. This evidence concerns the gene CPNE7 and colorectal carcinoma.